WHO ICTRP trial
An open-label, randomised, comparative, multi-centre study of the immunogenicity…
NL-OMON31421 · Overview of Medical Research in the Netherlands (NL-OMON) · Not Recruiting
Key facts
| Trial ID | NL-OMON31421 |
|---|---|
| Public title | An open-label, randomised, comparative, multi-centre study of the immunogenicity and safety of a 1-dose regimen and different 2-dose regimens of a Zoster vaccine (Live), ZOSTAVAX, in subjects >= 70 years of age |
| Scientific title | An open-label, randomised, comparative, multi-centre study of the immunogenicity and safety of a 1-dose regimen and different 2-dose regimens of a Zoster vaccine (Live), ZOSTAVAX, in subjects >= 70 years of age - Zostavax-study |
| Primary sponsor | Sanofi Pasteur MSD S.N.C. |
| Registry | Overview of Medical Research in the Netherlands (NL-OMON) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Phase | 3 |
| Countries | The Netherlands |
| Conditions | Herpes Zoster Shingles;10047438;Herpes Zoster;Shingles |
| Interventions | Randomisation will be done using a 1:1:1 ratio in 3 groups as follows: Group 1: ZOSTAVAX® at Day 0 only Group 2: ZOSTAVAX® at Day 0 and Month 1 (Day 28 to Day 35) Group 3: ZOSTAVAX® at Day 0 and Month 3 (Day 82 to Day 98)… |
| Registration date | Oct 5, 2007 |
| Target size | 150 |
| Secondary IDs | 2007-000744-28;NL18285.000.07 |
| Registry page | onderzoekmetmensen.nl |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: